logo
Editorial: Tissue engineering of the heart ☆
Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair ☆
Large-scale production of human pluripotent stem cell derived cardiomyocytes ☆
Hydrogels for therapeutic cardiovascular angiogenesis ☆
Self-assembling peptide-based delivery of therapeutics for myocardial infarction ☆
Alginate biomaterial for the treatment of myocardial infarction: Progress, translational strategies, and clinical outlook ☆
Decellularized myocardial matrix hydrogels: In basic research and preclinical studies ☆
Fibrous scaffolds for building hearts and heart parts ☆
Three-dimensional cardiac tissue fabrication based on cell sheet technology ☆
Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues ☆
Electrical and mechanical stimulation of cardiac cells and tissue constructs ☆
Mechanical stimulation in the engineering of heart muscle ☆
Biomechanical conditioning of tissue engineered heart valves: Too much of a good thing? ☆
Mechanical regulation of vascular network formation in engineered matrices ☆
Vascularization strategies of engineered tissues and their application in cardiac regeneration ☆
Bioengineering methods for myocardial regeneration ☆
In vitro cardiac tissue models: Current status and future prospects ☆
Human engineered heart tissue as a model system for drug testing ☆
Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening ☆
Engineered heart tissues and induced pluripotent stem cells: Macro- and microstructures for disease modeling, drug screening, and translational studies ☆
Regulatory aspects of small molecule drugs for heart regeneration ☆